jnj-26489112
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00579384)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
NS(=O)(=O)NC[C@H]1COc2cc(Cl)ccc2O1- Mol. weight
- 278.72 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3092995 ↗
Also known as
- jnj26489112
- jnj-26489112
- jnj-26489112
- jnj-26489112
- n-((6-chloro-2,3-dihydrobenzo(1,4)dioxin-2-yl)methyl)sulfamide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01114698 | Phase 2 | Mar 1, 2011 | Johnson and Johnson |
| NCT01147887 | Phase 1 | Jun 1, 2010 | Johnson and Johnson |
| NCT01949610 | Phase 1 | Jan 1, 2010 | Johnson and Johnson |
| NCT00579384 | Phase 2 | Oct 1, 2007 | Johnson and Johnson |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johnson and Johnson | For profit | 4 | 4 | 2 | 2007 |
1 organizations
Page 1 / 1